β-catenin | IDC cases (n = 135) | Control normal breast (n = 40) | Test of sig. | p | |||
---|---|---|---|---|---|---|---|
No. | % | No. | % | ||||
Positivity | Membranous | 0 | 0 | 40 | 100.0 | ||
Cytoplasmic | 92 | 68.1 | 0 | 0 | χ2=175.0* | <0.001* | |
Nucleocytoplasmic | 43 | 31.9 | 0 | 0.0 | |||
Percent | Min.–Max. | 45.0–95.0 | 70.0–95.0 | U=1688.0* | <0.001* | ||
Mean ± SD. | 75.74 ± 11.68 | 83.37 ± 8.35 | |||||
Median (IQR) | 80.0 (70.0–85.0) | 85.0 (75.0–90.0) | |||||
Intensity | Mild | 13 | 9.6 | 0 | 0.0 | χ2=17.949* | <0.001* |
Moderate | 32 | 23.7 | 0 | 0.0 | |||
Strong | 90 | 66.7 | 40 | 100.0 | |||
Mild + moderate | 45 | 33.3 | 0 | 0.0 | χ2=17.949* | <0.001* | |
Strong | 90 | 66.7 | 40 | 100.0 | |||
H score | Min.–Max. | 50.0–285.0 | 210.0–285.0 | U=1322.0* | <0.001* | ||
Mean ± SD. | 197.59 ± 63.75 | 250.13 ± 25.05 | |||||
Median (IQR) | 210.0 (157.5–247.5) | 255.0 (225.0–270.0) | |||||
Low (<210) | 55 | 40.7 | 0 | 0.0 | χ2=23.765* | <0.001* | |
High (>210) | 80 | 59.3 | 40 | 100.0 |